Enzyme Drives Treatment Resistance in Ovarian Cancer - News Center
Researchers at Northwestern Medicine identify PRMT5 as a key driver in chemotherapy resistance for advanced ovarian cancer, revealing potential targets for treatment.
Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies
Dostarlimab immunotherapy shows promise for treating solid tumors with fewer severe side effects, achieving remarkable tumor regression in clinical trials.
Cancer is the second leading cause of death globally, requiring urgent advancements in diagnosis and treatment to keep pace with the rising incidence.
Emerging biopharmaceutical companies are increasingly dominating the oncology clinical trial landscape, reflecting their growing importance in cancer research.
Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff
Cargo Therapeutics is laying off nearly all its employees after ceasing drug development due to trial failures, marking a major decline for the biotech firm.